METASTATIC RENAL-CELL CANCER - INTERLEUKIN-2 TOXICITY INDUCED BY CONTRAST AGENT INJECTION

被引：12

作者：

ABIAAD, AS

FIGLIN, RA

BELLDEGRUN, A

DEKERNION, JB

机构：

[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT INTERNAL MED,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024

[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT SURG,DIV UROL,LOS ANGELES,CA 90024

来源：

JOURNAL OF IMMUNOTHERAPY | 1991年 / 10卷 / 04期

关键词：

INTERLEUKIN-2; TOXICITY; NONIONIC CONTRAST MEDIA; METASTATIC RENAL CELL CARCINOMA;

D O I：

10.1097/00002371-199108000-00008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We describe a clinical syndrome occurring after contrast medium injection in patients who previously received recombinant interleukin-2 (rIL-2) and recombinant interferon-alpha-2A treatment for metastatic renal cancer. The clinical picture mimics many aspects of rIL-2-related systemic side effects. The patients were managed conservatively but the potential for severe manifestations can occur, requiring more intensive treatment.

引用

收藏

页码：292 / 295

页数：4

相关论文

共 12 条

[1] THE CURRENT STATUS OF REACTIONS TO INTRAVENOUS CONTRAST-MEDIA [J].

ANSELL, G ;

TWEEDIE, MCK ;

WEST, CR ;

EVANS, DAP ;

COUCH, L .

INVESTIGATIVE RADIOLOGY, 1980, 15 (06) :S32-S39

[2] EFFECTS OF INTERLEUKIN-2 ON RENAL-FUNCTION IN PATIENTS RECEIVING IMMUNOTHERAPY FOR ADVANCED CANCER [J].

BELLDEGRUN, A ;

WEBB, DE ;

AUSTIN, HA ;

STEINBERG, SM ;

WHITE, DE ;

LINEHAN, WM ;

ROSENBERG, SA .

ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :817-822

[3] A PROSPECTIVE RANDOMIZED TRIAL EVALUATING PROPHYLACTIC ANTIBIOTICS TO PREVENT TRIPLE-LUMEN CATHETER-RELATED SEPSIS IN PATIENTS TREATED WITH IMMUNOTHERAPY [J].

BOCK, SN ;

LEE, RE ;

FISHER, B ;

RUBIN, JT ;

SCHWARTZENTRUBER, DJ ;

WEI, JP ;

CALLENDER, DPE ;

YANG, JC ;

LOTZE, MT ;

PIZZO, PA ;

ROSENBERG, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) :161-169

[4] ADVERSE REACTIONS TO IONIC AND NONIONIC CONTRAST-MEDIA - A REPORT FROM THE JAPANESE-COMMITTEE-ON-THE-SAFETY-OF-CONTRAST MEDIA [J].

KATAYAMA, H ;

YAMAGUCHI, K ;

KOZUKA, T ;

TAKASHIMA, T ;

SEEZ, P ;

MATSUURA, K .

RADIOLOGY, 1990, 175 (03) :621-628

[5] AN ACQUIRED CHEMOTACTIC DEFECT IN NEUTROPHILS FROM PATIENTS RECEIVING INTERLEUKIN-2 IMMUNOTHERAPY [J].

KLEMPNER, MS ;

NORING, R ;

MIER, JW ;

ATKINS, MB .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (14) :959-965

[6] CONTRAST-MEDIUM RECALLS INTERLEUKIN-2 TOXICITY [J].

OLDHAM, RK ;

BROGLEY, J ;

BRAUD, E .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) :942-943

[7] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].

ROSENBERG, SA ;

LOTZE, MT ;

MUUL, LM ;

CHANG, AE ;

AVIS, FP ;

LEITMAN, S ;

LINEHAN, WM ;

ROBERTSON, CN ;

LEE, RE ;

RUBIN, JT ;

SEIPP, CA ;

SIMPSON, CG ;

WHITE, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897

[8]

ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735

[9] ADVERSE REACTIONS TO CONTRAST-MEDIA - A REPORT FROM THE COMMITTEE ON SAFETY OF CONTRAST-MEDIA OF THE INTERNATIONAL-SOCIETY-OF-RADIOLOGY [J].

SHEHADI, WH ;

TONIOLO, G .

RADIOLOGY, 1980, 137 (02) :299-302

[10] CONSTANT-INFUSION RECOMBINANT INTERLEUKIN-2 IN ADOPTIVE IMMUNOTHERAPY OF ADVANCED CANCER [J].

WEST, WH ;

TAUER, KW ;

YANNELLI, JR ;

MARSHALL, GD ;

ORR, DW ;

THURMAN, GB ;

OLDHAM, RK .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :898-905